Home > > > > > Report Detail

Traumatic Brain Injury - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Traumatic Brain Injury - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Traumatic Brain Injury epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2028

Traumatic Brain Injury Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Traumatic Brain Injury in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Traumatic Brain Injury outlook. It also includes the explanation of changing trends of epidemiology outlining the Traumatic Brain Injury scenario.

Traumatic Brain Injury Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Traumatic Brain Injury thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

- The report covers detailed overview of Traumatic Brain Injury explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The Traumatic Brain Injury Report assesses the disease risk and burden and highlights the unmet needs

- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

- 10 Year Forecast

- 7MM Coverage

- Total Cases in Traumatic Brain Injury

Key assessments

- Patient Segmentation in Traumatic Brain Injury

- Traumatic Brain Injury Risk & Burden

- Factors driving growth in a specific Traumatic Brain Injury patient population

Traumatic Brain Injury - Epidemiology Forecast to 2028

Table of Contents

1. Report Introduction
2. Traumatic Brain Injury Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Traumatic Brain Injury in 2016
2.2. Patient Share Distribution of Traumatic Brain Injury in 2028
3. Disease Background and Overview: Traumatic Brain Injury
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Traumatic Brain Injury in 7MM
4.3. Total Prevalent/ Incident Patient Population of Traumatic Brain Injury in 7MM - By Countries
5. Epidemiology of Traumatic Brain Injury by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Traumatic Brain Injury
5.1.3. Sub-Type Specific cases of the Traumatic Brain Injury *
5.1.4. Sex- Specific Cases of the Traumatic Brain Injury*
5.1.5. Diagnosed Cases of the Traumatic Brain Injury
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Traumatic Brain Injury
5.4.3. Sub-Type Specific cases of the Traumatic Brain Injury*
5.4.4. Sex- Specific Cases of the Traumatic Brain Injury*
5.4.5. Diagnosed Cases of the Traumatic Brain Injury
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Traumatic Brain Injury
5.5.3. Sub-Type Specific cases of the Traumatic Brain Injury*
5.5.4. Sex- Specific Cases of the Traumatic Brain Injury*
5.5.5. Diagnosed Cases of the Traumatic Brain Injury
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Traumatic Brain Injury
5.6.3. Sub-Type Specific cases of the Traumatic Brain Injury*
5.6.4. Sex- Specific Cases of the Traumatic Brain Injury*
5.6.5. Diagnosed Cases of the Traumatic Brain Injury
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Traumatic Brain Injury
5.7.3. Sub-Type Specific cases of the Traumatic Brain Injury*
5.7.4. Sex- Specific Cases of the Traumatic Brain Injury*
5.7.5. Diagnosed Cases of the Traumatic Brain Injury
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Traumatic Brain Injury
5.8.3. Sub-Type Specific cases of the Traumatic Brain Injury*
5.8.4. Sex- Specific Cases of the Traumatic Brain Injury*
5.8.5. Diagnosed Cases of the Traumatic Brain Injury
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Traumatic Brain Injury
5.9.3. Sub-Type Specific cases of the Traumatic Brain Injury*
5.9.4. Sex- Specific Cases of the Traumatic Brain Injury*
5.9.5. Diagnosed Cases of the Traumatic Brain Injury
6. Unmet Needs of the Traumatic Brain Injury
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Traumatic Brain Injury in 7MM
Table 2: Total Prevalent/Incident Cases of the Traumatic Brain Injury in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Traumatic Brain Injury in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Traumatic Brain Injury in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Traumatic Brain Injury in United States (2016-2028)*
Table 6: Diagnosed Cases of the Traumatic Brain Injury in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Traumatic Brain Injury in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Traumatic Brain Injury in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Traumatic Brain Injury in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Traumatic Brain Injury in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Traumatic Brain Injury in France (2016-2028)
Table 12: Sub-Type Specific cases of the Traumatic Brain Injury in France (2016-2028) *
Table 13: Sex- Specific Cases of the Traumatic Brain Injury in France (2016-2028) *
Table 14: Diagnosed Cases of the Traumatic Brain Injury in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Traumatic Brain Injury in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Traumatic Brain Injury in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Traumatic Brain Injury in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Traumatic Brain Injury in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Traumatic Brain Injury in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Traumatic Brain Injury in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Traumatic Brain Injury in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Traumatic Brain Injury in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Traumatic Brain Injury in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Traumatic Brain Injury in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Traumatic Brain Injury in UK (2016-2028) *
Table 26: Diagnosed Cases of the Traumatic Brain Injury in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Traumatic Brain Injury in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Traumatic Brain Injury in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Traumatic Brain Injury in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Traumatic Brain Injury in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Traumatic Brain Injury in 7MM
Figure 2: Total Prevalent/Incident Cases of the Traumatic Brain Injury in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Traumatic Brain Injury in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Traumatic Brain Injury in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Traumatic Brain Injury in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Traumatic Brain Injury in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Traumatic Brain Injury in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Traumatic Brain Injury in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Traumatic Brain Injury in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Traumatic Brain Injury in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Traumatic Brain Injury in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Traumatic Brain Injury in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Traumatic Brain Injury in France (2016-2028) *
Figure 14: Diagnosed Cases of the Traumatic Brain Injury in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Traumatic Brain Injury in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Traumatic Brain Injury in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Traumatic Brain Injury in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Traumatic Brain Injury in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Traumatic Brain Injury in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Traumatic Brain Injury in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Traumatic Brain Injury in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Traumatic Brain Injury in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Traumatic Brain Injury in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Traumatic Brain Injury in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Traumatic Brain Injury in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Traumatic Brain Injury in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Traumatic Brain Injury in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Traumatic Brain Injury in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Traumatic Brain Injury in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Traumatic Brain Injury in Japan (2016-2028)

  • Global Restless Legs Syndrome Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Restless Legs Syndrome market size was valued at US$ million in 2023. With growing demand in downstream market, the Restless Legs Syndrome is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Restless Legs Syndrome market. Restless Legs Syndrome are expected to show stable growth in the future market. However, product di......
  • Global Autism Spectrum Disorder Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 110
    Report Overview: Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Diagnosing autism spectrum disorder (ASD) can be difficult, since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child's behavior and development to make a diagnosis. Our report studies the market......
  • Global Epilepsy Therapeutics Market Research Report 2023
    Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 86
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Epilepsy Therapeutics market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - Cephalon - Novartis - Pfizer - Johnson & Johnson - GlaxoSmithKline - Sanofi - Sunovion Pharmaceuticals......
  • Global Autism Spectrum Disorder Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Autism Spectrum Disorder market: According to our latest research, the global Autism Spectrum Disorder market looks promising in the next 5 years. As of 2022, the global Autism Spectrum Disorder market was estimated at USD 464.19 million, and it's anticipated to reach USD 700.88 million in 2028, with a CAGR of 7.11% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......
  • Global Autism Spectrum Disorder Market Status and Outlook 2023-2028
    Published: 24-Nov-2023        Price: US 3160 Onwards        Pages: 109
    Autism spectrum disorder (ASD) is a complex developmental condition that involves persistent challenges in social interaction, speech and nonverbal communication, and restricted/repetitive behaviors. The effects of ASD and the severity of symptoms are different in each person. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segmen......
  • Global Epilepsy Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Epilepsy Therapeutics market: According to our latest research, the global Epilepsy Therapeutics market looks promising in the next 5 years. As of 2022, the global Epilepsy Therapeutics market was estimated at USD 11157.84 million, and it's anticipated to reach USD 13510.46 million in 2028, with a CAGR of 3.24% during the forecast years. Epilepsy is a group of neurological disorders characterized by seizures. The onset of a seizure can range from a b......
  • Global Gabapentin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 98
    Market Overview of Global Gabapentin market: According to our latest research, the global Gabapentin market looks promising in the next 5 years. As of 2022, the global Gabapentin market was estimated at USD 1627.13 million, and it's anticipated to reach USD 1844.92 million in 2028, with a CAGR of 2.12% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Gabapentin market, with a sys......
  • 2023-2031 Report on Global Autism Spectrum Disorder Market by Player, Region, Type, Application and Sales Channel
    Published: 09-Oct-2023        Price: US 2500 Onwards        Pages: 89
    This report studies the Autism Spectrum Disorder market, covering market size for segment by type (Center-Based, In-Home, etc.), by application (1-14 Years Old, 15-25 Years Old, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Otsuka, Astrazeneca, Pfizer, Eli Lilly, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Aut......
  • Global Gabapentin Market Insights, Forecast to 2029
    Published: 27-Sep-2023        Price: US 4900 Onwards        Pages: 112
    Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. The global Gabapentin market is projected to grow from US$ 1572.1 million in 2023 to US$ 1749.7 million by 2029, at a Compound Annual Growth Ra......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs